ES2660019T3 - Parche que contiene diclofenaco y tiocolchicósido - Google Patents

Parche que contiene diclofenaco y tiocolchicósido Download PDF

Info

Publication number
ES2660019T3
ES2660019T3 ES12733619.6T ES12733619T ES2660019T3 ES 2660019 T3 ES2660019 T3 ES 2660019T3 ES 12733619 T ES12733619 T ES 12733619T ES 2660019 T3 ES2660019 T3 ES 2660019T3
Authority
ES
Spain
Prior art keywords
thiocolchicose
patch containing
containing diclofenac
adhesive matrix
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12733619.6T
Other languages
English (en)
Inventor
Giuseppe IRIANNI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epifarma Srl
Original Assignee
Epifarma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epifarma Srl filed Critical Epifarma Srl
Application granted granted Critical
Publication of ES2660019T3 publication Critical patent/ES2660019T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Parche que contiene, disperso en una matriz adhesiva: - diclofenaco o una sal farmacéuticamente aceptable del mismo en cantidades que varían de 1 a 15 % en peso de la matriz adhesiva seca total, - tiocolchicósido en cantidades que varían de 0.1 a 5 % en peso de la matriz adhesiva total, y - excipientes farmacéuticamente aceptables.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES12733619.6T 2011-07-20 2012-06-15 Parche que contiene diclofenaco y tiocolchicósido Active ES2660019T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20111355 2011-07-20
IT001355A ITMI20111355A1 (it) 2011-07-20 2011-07-20 Cerotto transdermico contenente diclofenac e tiocolchicoside
PCT/EP2012/061468 WO2013010737A1 (en) 2011-07-20 2012-06-15 Patch containing diclofenac and thiocolchicoside

Publications (1)

Publication Number Publication Date
ES2660019T3 true ES2660019T3 (es) 2018-03-20

Family

ID=44545826

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12733619.6T Active ES2660019T3 (es) 2011-07-20 2012-06-15 Parche que contiene diclofenaco y tiocolchicósido

Country Status (14)

Country Link
US (1) US9220690B2 (es)
EP (1) EP2734196B1 (es)
JP (1) JP2014520867A (es)
CN (1) CN103702667A (es)
AU (1) AU2012286133A1 (es)
BR (1) BR112014001096A2 (es)
CA (1) CA2842273A1 (es)
EA (1) EA025793B1 (es)
ES (1) ES2660019T3 (es)
IL (1) IL230482A0 (es)
IT (1) ITMI20111355A1 (es)
MX (1) MX2014000751A (es)
WO (1) WO2013010737A1 (es)
ZA (1) ZA201400394B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104415024B (zh) * 2013-08-22 2018-05-11 和心医药科技（上海）有限公司 含双氯芬酸的巴布剂、及其组合物和制备方法
ES2991296T3 (es) 2014-10-17 2024-12-03 Fidia Farm Spa Sistema terapéutico dérmico de alta adhesividad
US11123414B2 (en) * 2017-12-22 2021-09-21 Produits Naturasense Inc. Non-carcinogenic cream for delivery of active ingredient into the dermis
USD980359S1 (en) 2021-01-20 2023-03-07 Karsten Manufacturing Corporation Golf club head
USD972674S1 (en) 2021-01-20 2022-12-13 Karsten Manufacturing Corporation Golf club head
USD1036594S1 (en) 2022-09-21 2024-07-23 Karsten Manufacturing Corporation Golf club head

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280426A (ja) 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
CH666621A5 (de) 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH0656660B2 (ja) 1990-05-18 1994-07-27 三洋電機株式会社 駆動電圧発生回路
JPH04261119A (ja) 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤
JP3086290B2 (ja) 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
FR2735369B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
JP4181232B2 (ja) 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
ITMI20012827A1 (it) * 2001-12-28 2003-06-28 Fidia Farmaceutici Formulazioni adesive transdermiche di diclofenac sodico
JP4764337B2 (ja) * 2004-04-23 2011-08-31 久光製薬株式会社 消炎鎮痛貼付剤
ITMI20041492A1 (it) * 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
ATE528370T1 (de) * 2005-03-17 2011-10-15 Pharmafilm S R L Wässriges polymersystem zur herstellung einer haftklebematrix
CA2677076C (en) * 2007-03-02 2017-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
IT1392180B1 (it) * 2008-12-11 2012-02-22 Bouty Spa Un sistema matriciale auto-adesivo comprendente un copolimero a blocchi stirenico
US20110244023A1 (en) * 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch

Also Published As

Publication number Publication date
MX2014000751A (es) 2014-10-15
JP2014520867A (ja) 2014-08-25
EP2734196B1 (en) 2017-12-06
CA2842273A1 (en) 2013-01-24
BR112014001096A2 (pt) 2018-10-30
EA201490041A1 (ru) 2014-05-30
ZA201400394B (en) 2015-05-27
EA025793B1 (ru) 2017-01-30
AU2012286133A1 (en) 2014-02-06
US9220690B2 (en) 2015-12-29
ITMI20111355A1 (it) 2013-01-21
EP2734196A1 (en) 2014-05-28
WO2013010737A1 (en) 2013-01-24
US20140155342A1 (en) 2014-06-05
IL230482A0 (en) 2014-03-31
CN103702667A (zh) 2014-04-02

Similar Documents

Publication Publication Date Title
ES2530170T3 (es) Material de filtro transparente
ES2496092T3 (es) El uso de amisulprida para tratar náuseas y vómitos posoperatorios
ES2509117T3 (es) Composición farmacéutica oral que contiene dabigatran etexilato
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
ES2574417T3 (es) Composición de gel
GT201400012A (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
EP3311802C0 (en) PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES
FI20116138A7 (fi) Matriisi bioaktiivisten aineiden hallittuun vapauttamiseen
AR128816A2 (es) Formas de dosificación farmacéutica de perlas de cisteamina
CO2017006898A2 (es) Formulación de relación fija de insulina glargina/lixisenatida
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
CL2013003143A1 (es) Uso de compuestos derivados de fenilaminopirimidinilo, un enantiomero o una sal farmaceuticamente aceptable del mismo para reducir la viabilidad de celulas de mieloma multiple en un estado de celulas no erspondedoras a il-6 y/o que tienen un fenotipo cd45-.
GT201500035A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
PE20151051A1 (es) Formulaciones de liberacion modificada para oprozomib
ES2552654T3 (es) Uso de LCAT para tratar la anemia y la disfunción de los glóbulos rojos
NI201000173A (es) Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre.
ES2527010T3 (es) Complejo de flurano
ES2508165T3 (es) Lactoferrina y sustancia blanca
ES2633762T3 (es) Hipertensión e hiperuricemia
EP2596062A4 (en) LIVING RADICAL POLYMERIZATION (LRP) WITH SINGLE-ELECTRO-TRANSFER (SET) OF ACRYLATES IN THE PRESENCE OF ACIDS
ES2619428T3 (es) Composición en polvo para desinfección de las ubres de los animales lecheros
ES2583004T3 (es) Olleya marilimosa y su uso en un método para la preparación de una composición que contiene zeaxantina
EA201490041A1 (ru) Пластырь, содержащий диклофенак и тиоколхикозид
ES2525833T3 (es) Supresión del crecimiento del cáncer y la metástasis mediante el uso de derivados de ácido nordihidroguayarético con 7-hidroxiestaurosporina